Physician profile
David A Velling
NPI 1467545210
$3,475.19
in general payments reported to CMS, 2019-2025
18 companies · $638 in 2025
The $638 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $365 · 2021: $211 · 2022: $507 · 2023: $282 · 2024: $1,007 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189 · Travel and Lodging: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.07 |
| Travel and Lodging | $737.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $808.01 | 2024-2025 | |
| Boston Scientific Corporation | $803.15 | 2019-2024 | |
| Nevro Corp. | $490.24 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $299.06 | 2024-2025 | Evoke |
| Abbott Laboratories | $284.41 | 2022-2024 | Proclaim, Eterna |
| Stimwave Technologies Incorporated | $281.65 | 2020 | |
| Lilly USA, LLC | $82.63 | 2019-2023 | Emgality, Reyvow |
| Nalu Medical, INC. | $76.04 | 2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $65.92 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $59.78 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $47.14 | 2025 | |
| Medtronic USA, INC. | $41.92 | 2019 | |
| Horizon Therapeutics Plc | $32.64 | 2019 | |
| Globus Medical, INC. | $23.75 | 2025 | Senza |
| Painteq LLC | $23.27 | 2024 | Painteq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.73 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.60 | 2019 | |
| Pfizer INC. | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Velling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.